Where Will Vaxart Inc (VXRT) Stock Go Next After It Is Down 6.10% in a Week?

Overall market sentiment has been down on Vaxart Inc (VXRT) stock lately. VXRT receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Vaxart Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VXRT!

See Full VXRT Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With VXRT Stock Today?

Vaxart Inc (VXRT) stock is trading at $0.77 as of 3:22 PM on Friday, Sep 8, an increase of $0.03, or 3.99% from the previous closing price of $0.74. The stock has traded between $0.74 and $0.83 so far today. Volume today is above average. So far 1,354,010 shares have traded compared to average volume of 1,046,094 shares. To screen for more stocks like Vaxart Inc click here.

More About Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. Click Here to get the full Stock Report for Vaxart Inc stock.